首页> 外文期刊>Korean Circulation Journal >Baseline Characteristics of a Retrospective Patient Cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry
【24h】

Baseline Characteristics of a Retrospective Patient Cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry

机译:韩国血管介入学会下肢动脉疾病(K-VIS ELLA)注册中心的回顾性患者队列的基线特征

获取原文
       

摘要

Background and Objectives The Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry is a multicenter observational study with retrospective and prospective cohorts of patients with lower extremity peripheral artery disease (PAD) undergoing endovascular treatment. In this study, we report the baseline characteristics of this retrospective cohort. Subjects and Methods In the present study we analyzed datasets of 3073 patients with 3972 target limbs from a retrospective cohort treated with endovascular therapy in 31 Korean hospitals. Data regarding patient baseline clinical and lesion characteristics and postintervention medications were collected from electronic medical records. Results The mean patient age was 68.3±9.4 years. The majority were male (82.1%) with comorbidities such as diabetes mellitus (58.0%), hypertension (73.4%), and coronary artery disease (CAD; 55.3%). Patients more commonly presented with intermittent claudication (66.3%) than with critical limb ischemia (CLI; 33.7%). Femoropopliteal artery (41.2%) was the most common target vessel for endovascular treatment, followed by the aortoiliac (35.6%) and infrapopliteal arteries (23.2%). TransAtlantic Inter-Society Consensus for the Management of Peripheral Artery Disease (TASC II) type C/D aortoiliac (48.0%) or femoropopliteal lesions (60.2%) were frequent targets of endovascular treatment. At hospital discharge, only 73.1% of patients received dual antiplatelet therapy and 69.2% received a statin. Conclusion The majority of Korean patients with PAD exhibited conventional risk factors, such as male sex, older age, diabetes, and hypertension with coexisting CAD. Complex lesions were frequently treated with endovascular therapy. However, the rate of adherence to guidelines regarding post-procedural medical treatment requires improvement.
机译:背景与目的韩国血管介入学会下肢动脉疾病血管内治疗(K-VIS ELLA)注册中心是一项多中心观察性研究,对接受血管内治疗的下肢周围动脉疾病(PAD)患者进行回顾性和前瞻性队列研究。在这项研究中,我们报告了该回顾性队列的基线特征。受试者与方法在本研究中,我们分析了韩国31家医院接受血管内治疗的回顾性队列研究的3073例患肢3972例患者的数据集。从电子病历中收集有关患者基线临床和病变特征以及干预后用药的数据。结果患者平均年龄为68.3±9.4岁。多数是男性(82.1%),合并症如糖尿病(58.0%),高血压(73.4%)和冠心病(CAD; 55.3%)。与间歇性肢体缺血(CLI; 33.7%)相比,间歇性lau行(66.3%)更为常见。 emo动脉(41.2%)是血管内治疗的最常见靶血管,其次是主动脉(35.6%)和in下动脉(23.2%)。跨大西洋社区间动脉疾病(TASC II)管理的共识是C / D型主动脉c(48.0%)或股pop病变(60.2%),是血管内治疗的常见目标。出院时,只有73.1%的患者接受了双重抗血小板治疗,而69.2%的患者接受了他汀类药物。结论韩国大多数PAD患者均表现出常规危险因素,如男性,老年,糖尿病和高血压并存CAD。复杂的病变常采用血管内治疗。但是,遵守有关术后医学治疗指南的比率需要提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号